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ABSTRACT 
Studies of the immune system requires knowledge concerning not only the perturbating event 
itself, i.e. specific microorganisms, and how it interacts with immune cells but also how it 
functions in its natural environment – tissues. The non-hematopoietic component of tissues 
contributes immensely to all immune responses and acknowledging its contribution have been 
central to immunological research during the last decade.  
The work in this thesis focuses on the use of a three-dimensional organotypic lung tissue model, 
which recapitulates many aspects of its in vivo correlate. Study I describe the properties of the 
organotypic tissue model and implanted monocyte-derived dendritic cells. In Study II we show 
how the organotypic tissue model can be used to study, not only secreted factors influenced by 
dendritic cells, but also a key functional property of dendritic cells – cell migration. In Study 
III, we used the tissue model to model a staphylococcus aureus infection, and in particular how 
derived toxins such as alpha-toxin and Panton-Valentine Leukocidin (PVL) contribute to tissue 
pathology. Immunological downstream effects of staphylococcal toxins are further explored in 
Study IV, where we investigate the role of ADAM10 and CX3CL1 (fractalkine) in alpha-toxin 
mediated pathology. In Study V, the goal was to set up a model system in which it is possible 
to study the interaction between immune cells, tissue model and tumor cells, analogous to 
Study III and IV.  
The studies here provide a framework for how complex, multicellular in vitro systems can be 
used in immunological studies in context to inflammation-driven pathologies. The validity of 
the model system remains to be studied, and the role for organotypic tissue models in medical 
research is yet to be determined. However, it is becoming increasingly clear that the study of 
disease mechanisms relating to inflammation will benefit from added complexity and 
acknowledgement that cells such as epithelial cells and fibroblast are active contributors to 
immune responses and tissue pathology. 
  
 2 
LIST OF SCIENTIFIC PAPERS 
Studies included in the thesis are referred to as Study I-V. 
 
 
 
 
 
 
 
 
 
 
 
 
 
I. Nguyen Hoang AT, Chen P, Juarez J, Sachamitr P, Billing B, Bosnjak L, et 
al. Dendritic cell functional properties in a three-dimensional tissue model of 
human lung mucosa. Am J Physiol Lung Cell Mol Physiol. 2012 
Jan;302(2):226–37.  doi: 10.1152/ajplung.00059.2011. 
 
II. Nguyen Hoang AT*, Chen P*, Björnfot S, Högstrand K, Lock JG, Grandien 
A, et al. Technical advance: live-imaging analysis of human dendritic cell 
migrating behavior under the influence of immune-stimulating reagents in an 
organotypic model of lung. J Leukoc Biol. 2014 Sep;96(3):481-9.  doi: 
10.1189/jlb.3TA0513-303R. 
*Equal contribution 
 
III. Mairpady Shambat S, Chen P, Nguyen Hoang AT, Bergsten H, Vandenesch 
F, Siemens N, et al. Modelling staphylococcal pneumonia in a human 3D lung 
tissue model system delineates toxin-mediated pathology. Dis Model Mech. 
2015 Nov;8(11):1413-25.  doi: 10.1242/dmm.021923. 
 
IV. Mairpady Shambat, S*, Chen P*, Barilla RM, Snäll J, Welin A, Cohen TS, 
et al. Alpha-toxin-elicited CX3CL1-release via ADAM10 in Staphylococcus 
aureus pneumonia impairs bactericidal function of human monocytes. 
Manuscript 
*Equal contribution 
 
V. Chen P, Svensson M. Immune-regulatory properties of human myeloid cells 
in a three-dimensional lung tumor model. Manuscript  
  3 
OTHER PUBLICATIONS NOT INCLUDED IN THE THESIS 
Listed in order of publication date. Studies not included in the thesis are referred to as Paper 
VI-XI.  
 
 
VI. Kvedaraite E, Lourda M, Ideström M, Chen P., Olsson-Åkefeldt S, Forkel 
M, et al. Tissue-infiltrating neutrophils represent the main source of IL-23 in 
the colon of patients with IBD. Gut. 2016 Oct;65(10):1632–41.   
 
VII. Marquardt N, Kekäläinen E, Chen P, Kvedaraite E, Wilson JN, Ivarsson MA, 
et al. Human lung natural killer cells are predominantly comprised of highly 
differentiated hypofunctional CD69-CD56dim cells. J Allergy Clin Immunol. 
2017 Apr;139(4):1321–30.e4. 
.  
VIII. Svensson M, Chen P. Human Organotypic Respiratory Models. In: Current 
Topics in Microbiology and Immunology. Springer, Berlin, Heidelberg 
 2018. p. 1-26. 
 
IX. Svensson M, Chen P. Novel models to study stromal cell-leukocyte 
interactions in health and disease. In: Owens BMJ & Lakins MA, editors. 
Stromal Immunology. Advances in Experimental Medicine and Biology, vol 
1060. Springer, Cham. 2018. p. 131-46. 
 
X. Martin OCB, Bergonzini A, D'Amico F, Chen P, Shay JW, Dupuy J, et al. 
Infection with genotoxin-producing Salmonella enterica synergises with loss 
of the tumour suppressor APC in promoting genomic instability via the PI3K 
pathway in colonic epithelial cells. Cell Microbiol. 2019 Aug;21(12):e13099.  
 
XI. Huhn O, Ivarsson MA, Gardner L, Hollinshead M, Stinchcombe JC, Chen P, 
et al. Distinctive phenotypes and functions of innate lymphoid cells in human 
decidua during early pregnancy. Nat Commun. 2020 Jan 20;11(1)1:381. 
 4 
CONTENTS 
Abstract ................................................................................................................................. 1 
1 Foreword ........................................................................................................................ 7 
2 Introduction .................................................................................................................... 8 
2.1 Host defense systems ........................................................................................... 8 
2.1.1 Non-hematopoietic components of the immune system ......................... 8 
2.1.2 The innate immune cells response ......................................................... 10 
2.1.3 The consequences of dysregulated adaptive immune responses. ......... 12 
2.2 Cell culturing ...................................................................................................... 13 
2.2.1 Conventional cell culturing ................................................................... 13 
2.2.2 3D cell culturing systems and other complex model systems .............. 14 
2.3 Tissue perturbation ............................................................................................. 15 
2.3.1 Invading microorganisms ...................................................................... 16 
2.3.2 Tumor growth ........................................................................................ 16 
3 Litterature review ......................................................................................................... 19 
3.1 The relevance of organotypic tissue models in studying Immune cell 
behavior in health and disease ........................................................................... 19 
3.2 Role of chemokines in shaping the innate immune system .............................. 19 
3.3 Pathogenesis of Staphylococcus aureus ............................................................ 21 
3.4 Immune-regulating properties of the tumor microenvironment. ...................... 22 
4 Material & Methods ..................................................................................................... 23 
4.1 Organotypic tissue model .................................................................................. 23 
4.2 Mononuclear phagocytic cells ........................................................................... 24 
5 Results & Discussion ................................................................................................... 26 
5.1 Study I ................................................................................................................ 26 
5.2 Study II ............................................................................................................... 27 
5.3 Study III ............................................................................................................. 29 
5.4 Study IV ............................................................................................................. 30 
5.5 Study V ............................................................................................................... 31 
6 Concluding remarks ..................................................................................................... 33 
7 Acknowledgement ....................................................................................................... 35 
8 References .................................................................................................................... 37 
 
  5 
LIST OF ABBREVIATIONS 
2D Two-dimensional 
3D Three-dimensional 
ADAM10 A Disintegrin and metalloproteinase domain-containing 
protein 10 
AM Alveolar macrophage 
BAL Bronchoalveolar lavage 
CAF Cancer-associated fibroblast 
COPD Chronic obstructive pulmonary disorder 
DAMP Danger-associated molecular pattern 
DC Dendritic cell 
ECM Extracellular matrix 
GFP Green fluorescent protein 
GM-CSF Granulocyte-macrophage colony-stimulating factor 
HBOC Heriditarey breast and ovarian cancer 
HIV Human immunodeficiency virus 
HMGB1 High Mobility Group Box 1 
IFNg Interferon gamma 
IL Interleukin 
IM Interstitial macrophage 
IVIG Intravenous immunoglobulin 
moDC Monocyte-derived dendritic cell 
MRC-5 Medical Research Council cell strain 5 
MRSA Methicillin-resistant Staphylococcus aureus 
MyD88 Myeloid differentiation primary response 88 
PAMP Pathogen-associated molecular pattern 
PD-1 Programmed cell death protein 1 
PD-L1 Programmed death-ligand 1 
PMN Polymorphonuclear cell 
PRR Pattern Recognition Receptor 
PVL Panto-Valentine leucocidin 
 6 
RSV Respiratory syncytial virus 
SV40 Simian Virus 40 
TAM Tumor-associated macrophages 
Th T-helper 
TLR Toll-like receptor 
TNF Tumor necrosis factor 
TSLP Thymic stromal lymphopoietin 
VEGF Vascular endothelial growth factor 
 
  7 
1 FOREWORD 
This thesis explores tissue inflammation in an experimental three-dimensional (3D) lung tissue 
model, especially the interplay between myeloid cells, lung epithelial cells and a defined tissue-
perturbating event – such as an infection or tumor growth. Thus, critical examination of this 
thesis requires some basic knowledge in immunology and cell culture methods. The main goal 
of this kappa is not only to provide context to the included papers, but give you as a reader 
insight into my thinking regarding tissue inflammation, myeloid cells and tissue culturing as 
an experimental model, the central themes of this thesis. The journey began with the goal of 
developing (Study I-II) and utilizing the organotypic lung model for modelling cancer (Study 
V), but slowly emerged to be centered around tissue inflammation as work involving 
Staphylococcus aureus toxins became of particular interest in our group (Study III-IV). As 
you will learn, the work in this thesis is oriented around method development. Study III-V 
have a translational trajectory but are focused on the organotypic tissue model in two clinical 
settings as a proof-of-concept, rather than trying to define or delineate pathophysiological 
mechanisms. 
The ‘2. Introduction’ in this thesis serves two different purposes. i) an introduction of some 
basic concepts for the uninitiated in immunology and tissue biology, but with a basic 
background in cell biology and ii) a glimpse into my personal perspective on this subject that 
could explain my approach the scientific questions and aims of the different studies laid out in 
this thesis. For more comprehensive reviews on immunology, microbiology or tumor biology 
as well as cell culture techniques, I would refer to textbooks focusing on the respective subject.  
In the next section, “3 Literature Review”, I will focus on key published research pertaining to 
the studies included in this thesis as a backdrop for the results & discussion to each study.  
‘4 Material & Methods’ and ‘5 Results & Discussion’ are sections where I summarize the 
main points from the included papers and bring up aspects that for different reason were not 
included in the published version.   
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2 INTRODUCTION 
2.1 HOST DEFENSE SYSTEMS 
2.1.1 Non-hematopoietic components of the immune system 
The immune system’s principal function is to defend us against invading pathogens and 
maintaining a healthy steady state in all tissues (1). However, the immune system is heavily 
fortified by i) anatomical barriers, ii) biological products and iii) commensal flora and are 
absolutely indispensable as we would be quickly overrun by invading pathogens without any 
one of them. Understanding these components of the host defense system also aid in 
understanding how microorganisms are equipped to cause disease and increase their likelihood 
of survival.  
Anatomical barriers refer to tissues that are exposed to the outside world, including oral 
mucosa, lung respiratory epithelium and the intestine. An important feature of the epithelial 
linings is the segregation of commensal flora and immune cells. The separation of commensal 
flora and the immune system allows for a non-reactive steady state, where the commensal flora 
can participate in the protection of tissue-harming microbes by competition of nutrients, 
altering of pH and hinderance of adherence (2,3). These anatomical barriers comprise of a 
complex and diverse set of cells, including epithelial cells, fibroblasts and endothelial cells, 
that continuously communicate with each other to maintain vital organ functions. The barrier 
primarily serves as a physical barrier to prevent pathogens reaching vulnerable vital organs, 
but also directly participates in the immune response by responding to the external environment 
and translates the information to resident immune cells. In organs such as lung and gut, the 
epithelium is one cell layer thick in order to allow for efficient transport of molecules between 
the external and internal environment. Because these organs are so exposed, they are also 
important avenues for pathogenic invasion and disease.  
The top 2 causes of death in low-income countries are lower respiratory infections and diarrheal 
diseases, accounting for 9,3% and 7,2% of total deaths respectively. In the outermost branches 
of the respiratory tree, the host is protected by a single, ultra-thin layer of epithelial cells that 
allows for efficient gas-exchange between the air-filled alveolar space and the pulmonary 
capillaries. The space between is functionally protected by pre-formed anti-microbial products 
and a variety of immune cells capable of quickly eliminating pathogens with minimum 
induction of inflammation. In contrast to many other organs, inflammation in the lung can 
quickly become a hazardous host-response, as slightest fluid retention impairs gas-exchange to 
a significant degree. A form of hypo-responsiveness in the lung immune compartment is 
therefore an important concept in steady state respiratory epithelium (2,3)  
The evolutionary pressure of infectious diseases in particular have likely shaped the structure 
of the immune system to its current form. It could be envisaged that the organization of the 
immune system towards combating infectious diseases have its downside in the context of non-
communicable diseases, which historically likely had a lower evolutionary pressure. Diseases 
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such as coronary heart disease, cancer, chronic obstructive pulmonary disease (COPD) are now 
leading causes of death as our ability to fend of the most common infectious diseases have 
greatly improved. Could it be so that the way the immune system had to be organized in a 
certain way to cope with the constant exposure of infectious diseases and that specific 
organization had weaknesses that we now witness in the era of modern medicine? Thus, 
studying the immune system from a microorganism’s perspective, will likely aid in the 
understanding of other inflammation-driven chronic disorders. 
From an immunologist’s perspective, the expansive arsenal of cell products, many of which 
originate from the cell types forming the physical barrier that specifically combat invading 
pathogens are of particular interest. These include anti-microbial enzymes, mucus and 
defensins that directly interacts with the infectious agent by disrupting important functions such 
as their cell wall integrity and ability to adhere to epithelial surfaces. Other molecules have a 
more indirect contribution to the first lines of defense. These molecules include cytokines, 
chemokines and different kind of hormones and function as first messenger to amplify more 
complex and specific functions that is tailored towards the infectious agent. Understanding the 
immunological failings and successes in an infection starts by understanding which set of 
molecules are released and consequently which inflammatory characteristics are induced to 
deal with a particular perturbating event.  
Considering the plethora of microorganisms that we constantly inhale with each breath and the 
known colonization of nasopharynx; it was until surprisingly recently that the lung was 
considered a sterile environment in steady state. However, one could forgive such an 
assumption as the thin lining of mucus throughout the respiratory tree is constantly propelled 
towards the nasopharynx. This feature, combined with the frequent branching of the conducting 
airway make it nearly impossible for inhaled organisms, or particles of any significant size 
(>1µm) to reach the lower respiratory airways. The ‘sterility assumption’ was primarily based 
on that no microorganisms were successfully cultured ex vivo using conventional bacteria-
culturing methods (4,5). However, the rise of culture-independent microbiology have 
completely changed this notion. Recent data suggest that bacteria found in the lower respiratory 
tract mirrors the microbiome found in the upper respiratory tract, but lower in density (6). 
Fewer studies have looked into the presence of fungus in the respiratory tract during steady 
state, and are more often associated with a dysfunctional immune system or co-infection (7,8). 
Commensal microbiota plays an important role in health and disease, but the role of the 
respiratory microbiota is less explored than that of the intestine and skin. For example, 
antibiotic treatment can result in the growth of Clostridium difficile or Candida spp in the gut 
– however, similar patterns are not as obvious in the respiratory tract. Clinically, antibiotic-
related pneumonias does not exist and although an abnormal microbiome can be detected in 
several pulmonary disorders, i.e. cystic fibrosis, it is not known if changes in the commensal 
microbiota can contribute to the initiation or exacerbation of different pulmonary diseases.   
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2.1.2 The innate immune cells response 
When physical barriers are breached and pre-formed cell products have been evaded – a more 
complex defense system is mobilized, the innate immune system. The innate immune system 
comprises of a group of immune cells without antigen-specificity and respond to conserved 
microbial structures. They have a key role in patrolling the tissue, as well as quickly respond 
to any sign of breach of anatomical barriers. In short, there are three groups of innate immune 
cells – i) granulocytes which are fast, reactive cells with high capacity to phagocytose and 
secrete large amounts of cytokines, ii) mononuclear phagocytic system (MPS) which have a 
primarily coordinating and regulatory role between the adaptive and the innate immune system 
and iii) innate cells of lymphoid origin such as NK-cells and innate lymphoid cells (ILCs) 
which are important in cell-mediated immune responses and mucosal defense. 
In a generic, simplified infection scenario, the first immune cell to encounter a pathogen are 
dendritic cells (DCs). DCs are professional antigen-presenting cells and the archetype tissue-
sampling cell, ready to receive and report signs of microbial perturbation. The so-called 
‘sensing’ is based on the concept of Pattern Recognition Receptors (PRRs) that recognizes 
danger, i.e. when a cell dies and intracellular content is leaked into the extracellular space, or 
traces of microorganisms in the form of conserved microbial structures, for example bacterial 
cell wall components. The PRRs respond to Danger Associated Molecular Patterns (DAMPs) 
from the host and Pathogen Associated Molecular Patterns (PAMPs) from invading pathogens. 
Both PAMPs and DAMPs induce inflammation through various receptors. The most well-
studied class of PRRs are Toll-like receptors (TLRs). Both DAMPs and PAMPs can signal via 
TLRs, although some DAMPs only signal through specific receptors and vice versa. Presence 
of DAMP-molecules can also be a sign of infection. As a general rule, activation of PRRs lead 
to activation of cells and induction of a proinflammatory response. The signaling pathways 
between infection, sterile/chronic inflammation and tissue damage are all closely intertwined, 
and finding parallels between autoimmune diseases, cancer and infections in terms of 
inflammatory profiles is not hard. For example, cancer have similarities to a viral infection in 
that it ‘resides’ intracellularly (DNA damage) and redirects the cell’s protein machinery and is 
most efficiently combated when a strong cellular response is mounted whereas autoimmune 
diseases can be compared to a chronic infection where the exaggerated and prolonged 
inflammatory response result in collateral tissue damage.  
A good example of a DAMP molecule is HMGB1, a nuclear protein that binds to the cell’s 
DNA. During necrosis, HMGB1 is released to the extracellular space and triggers 
inflammation. But HMGB1 can also be released via active secretion by monocytes upon 
stimulation with bacterial components or inflammatory cytokines (9,10). Molecules that 
activate PAMP receptors are often derived from microbe-defining structures such as flagellin 
(TLR-5 ligand) and LPS (TLR-4 ligand). In human lung macrophages, the acute inflammatory 
profile is similar when stimulating with most of the TLRs (11). Similarities in the response 
between different TLRs could be explained by the limited set of intracellular adaptor molecules 
that are recruited to the TLR upon TLR engagement. Conversely, differences in responses can 
be attributed to the differential engagement of adaptor molecules. For example, MyD88 (one 
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of four TLR adaptor molecules)-dependent secretion of proinflammatory cytokines is a 
consequence of signaling from all TLRs except TLR3. And TLR3, TLR4, TLR7 and TLR9, 
but not TLR2, induces type I interferons. Furthermore, the expression pattern of Toll-like 
receptors (TLRs) differ between cell type and organ and could also explain differences in TLR-
responses.  
Although the purpose of TLR-signaling is to induce a response in order to reverse the state of 
the tissue into its steady state, diseases such as cancer and autoimmune diseases are associated 
with, albeit dysfunctional, activation of PRRs (12-14). It is important to note that immune cells 
are, in most cases, not the first cells to encounter and respond to microorganisms. For example, 
lung epithelial cells express all known Toll-like receptors (15) but their role in TLR-mediated 
immune activation is not clear (16,17). 
Following PRR-activation, neutrophils are quickly recruited to the site, and infiltrating and/or 
resident mast cells and eosinophils secrete large amounts of cytokines. If this acute phase of 
the immune response is not sufficient, the adaptive arm of the immune system needs to be 
mobilized to strengthen and complement the innate immune cells. Key to the activation of the 
adaptive immune system is dendritic cells (DCs). DCs are commonly described as “the 
conductors of the immune system” but can also be likened to the “central alarm hub”, that 
notifies the appropriate authorities to respond to ongoing perturbations. Dendritic cells are 
especially well equipped to be sentient units as their dendrites covers large areas and, in contrast 
to other sentient cells such as epithelial cells, are able to ingest, process and present the material 
to antigen-specific lymphocytes. This is important both for the activation of lymphocytes but 
also for the retention of activated lymphocytes during viral pneumonias (18). 
The relationship between monocytes and dendritic cells is being increasingly nuanced the last 
two decades. Textbooks from the late 90s and early 00s would mention Langerhans cells as the 
first described dendritic cell (19), which had potent T cell-stimulatory capacity (20), in contrast 
to monocytes, macrophages and monocyte-derived macrophages. Monocytes were widely 
believed to be a precursor of certain types of macrophages and dendritic cells, shaped by the 
local microenvironment – and were attributed little or no specific functions other than being a 
precursor cell. Fast-forward 20 years and we today know, through detailed unravelling of the 
myeloid compartments ontogeny, that Langerhans cell are in fact more closely related to 
macrophages than dendritic cells (21), and that monocytes play a far more important role than 
just being a precursor cell (22,23). The differences between inflammation-driven 
differentiation of new dendritic cells and macrophages and the ontogeny of steady-state 
dendritic cells and macrophages is now becoming increasing clear, and much of the early work 
on the mononuclear phagocytic system needs to be reevaluated through this lens (24). Although 
monocyte-derived dendritic cells and de novo dendritic cells share many cell biological 
features, such as migration, phagocytosis, cytokine secretion, antigen processing and antigen 
presentation, their contributory role in the initiation, exacerbation or sustenance of a disease 
may differ significantly. During local inflammation, the number of dendritic cells increase 
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substantially as a consequence of monocytic differentiation (25-27). The role of circulating, 
conventional dendritic cells during an infection in peripheral tissue remains unclear.   
2.1.3 The consequences of dysregulated adaptive immune responses. 
The innate immune system’s secondary function is to activate the adaptive immune system. It 
does so in parallel to fighting the primary infection or tissue perturbation, before it is 
determined if the invading pathogen overcomes the first lines of defense. The details of the 
different adaptive immune cells and how they function are outside the scope of this thesis, 
however the concept of activation and inhibition of the adaptive immune system by innate 
immune cells is an important feature that deserves attention.  
Analogous to the parallel activation of the adaptive immune cells, systems to shut down the 
immune system is being set into motion before the infection is cleared. These “inhibitory” 
systems are required both to limit the collateral damage and to slowly shut down the potent 
response when the infection is over. An alternative term would be “regulatory” systems, as the 
main purpose is not to inhibit the response towards pathogens, but to regulate the response to 
make certain it is appropriate in style and adequate in strength during the different phases of 
the infection. As to be expected, this regulatory system can be hijacked and is a common 
strategy for tumor cells to perform immune evasion. Tumor immune evasion strategies are 
particularly interesting as an indiscriminate dampening of the tissue-inflammation is not 
desirable. Late-phase, chronic inflammation is associated with processes that benefits tissue 
repair. This include secretion of anti-apoptotic molecules, induction of angiogenesis and 
induction of T cell tolerance which is highly desirable features for a cancer microenvironment 
(28).  
Initiation, induction, sustenance and termination of any immune response are shared features 
and are each associated with tissue-related functions other than the immune cell-specific 
functions that is often well studied and taught in school. Understanding the tissue-related 
functions gives another dimension of context when understanding the different molecules at 
play, and gives nuance to the differences between invading pathogens and the pathogenesis of 
the corresponding diseases.  
Overzealous, misdirected or otherwise blunted adaptive immune responses are common 
features in many of the non-communicable diseases that we suffer from in the western world, 
including ischemic heart failure, diabetes, and neurological disorders. The origin may have 
dietary, infectious or degenerative reasons but in many cases ultimately lead to an unwanted 
adaptive immune response that initiates and exacerbates the actual pathology.  What all of these 
conditions have in common is the chronic nature of the inflammation, and chronic 
inflammation always have a component of adaptive immune response to sustain the pathology. 
The enormous success of checkpoint inhibitors in treating malignant tumors is a testament to 
the potential of proper control of the adaptive immune response. Other biologicals targeting 
cytokines and chemokines are all strong candidates for future personalized, 
immunomodulatory treatment regimens, but it is becoming increasingly clear that our 
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understanding for how to best fine-tune and the root-cause of many diseases is very limited at 
best. High levels of a cytokine or relative expansion of a cell subset may merely be a 
consequence of a slightly unregulated, and disrupted phase of the infectious cycle and not a 
root cause of the disease. Understanding the immune system through the lens of microbes will 
very likely provide great insight into treating non-communicable diseases such as cancer, heart 
failure and COPD.  
2.2 CELL CULTURING 
All research is in some way dependent on models. Depending on which field of research you 
operate in, the model can be more or less theoretical in its nature. The overwhelming majority 
of models are imperfect representations of the truth, and careful interpretation of models is at 
the heart of any good research. In medicine, we are many times asking questions that are 
complex in that many systems, in which we have limited knowledge of, interact. The limited 
knowledge in each system can easily become amplified when studying complex human 
diseases. A common approach to studying immune cells are to i) isolate cells from blood ii) 
put them in a petri-dish like culture and iii) add a perturbating agent/molecule. Sustaining these 
models required well-controlled temperatures, nutritious media and reductionistic approaches 
that required as few “unknown” factors in order to have a reproducible experiment. However, 
commonly used techniques for in vitro culturing of cells can actually be considered a 
refinement from the first cell culture experiments that often relied on what we today refer to 
explant models. The monolayer single cell cultures in defined cell culturing media we are so 
familiar with is, to a large extent, a way of increasing reproducibility as well as specificity in 
our experiments. 
The requirement of reproducibility is fundamental for making any conclusions from any 
experiments but have historically been an important limiting factor for the type of questions 
that can be asked. Many aspects of a cell-culturing protocol are in fact different ways to 
compensate for a suboptimal new environment or model. As our understanding of which 
factors are important for cell behavior in vivo have increased, the more ingenious ways of 
compensating for the suboptimal environment we come up with as biotechnology continuously 
revolutionize how we do research. Access to genetic engineering, and development of specific 
antibodies and small molecules to target desired molecules provide clarity to the answers of the 
questions being interrogated. It is not nostalgia, but the pursuit of better model system in which 
we are once again glancing on the prospect of using multicellular, complex tissues as the basis 
for our experiments to model immune responses, tumor development and pathogenesis of 
infectious diseases.  
2.2.1 Conventional cell culturing 
In this case, “conventional” does not necessary mean “first”. Early in vitro cell cultures, dating 
back to late nineteenth century, included skin tissues grown in agar and coagulated serum, 
tumor tissue from dogs and cats in plasma from the same source and undefined cells of the 
neural plate of chick and frog embryos cultured using saline buffers in hanging drops. In 1907, 
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Ross G. Harrison pioneered the first primary in vitro cultures of developing nerve fibers. The 
main problem with early in vitro cell cultures were i) short life span and ii) contamination of 
unwanted cell types. Today, we have technologies that enables a highly reproducible 
environment and specificity of cell isolation. However, studying these cell types in the very 
advantageous environment, but not allowing for interaction between different cell types, 
formation of 3D structures and exposure to more complex, but physiological, environments 
such as air and scaffolding proteins will affect their phenotype negatively. Processes that are 
less dependent on its environment, such as the fundamentals of cell replication, protein 
synthesis and DNA repair are ideal to study in this type of experimental settings, but other more 
complex processes such as cell migration that heavily depend on scaffolding, cell-cell contact, 
spatial distribution of chemokines and their association to ECM proteins will likely be affected 
in most conventional cell culture-experiments. To model the complexity of any human disease 
is an increadible hard, if not impossible, task. The most conventional way to study diseases is 
to use reductionistic in vitro cell cultures of human cells to generate and test hypotheses, and 
validate hypotheses in animal models, which are regarded to be more complex and 
representative of what happens inside the human body. But animal models are expensive, 
laborious and may or may not be relevant in humans in the end. The pharmaceutical industry 
regularly tests thousands of compounds and need a relevant model system to screen for the best 
candidate prior starting a clinical trial, as failure in the late stages of clinical trials are extremely 
expensive. Specificity and sensitivity are still an issue, and better models have the potential to 
drastically increase the likelihood of finding good pharmaceutical candidates.  
2.2.2 3D cell culturing systems and other complex model systems 
As tools have developed to create more complex cell culture systems, scientist have tried to 
mimic different aspects of the human organs (Paper VIII, Paper IX). A good example of 
refined technology to mimic physiological environments are flow based systems. The sheer 
stress of blood flow has significant impact on the endothelial phenotype, and immune cell 
extravasation undergo a series of important changes to latch on to and interact with the 
endothelium to eventually penetrate through (29). Initially, flow systems were also based on 
the use of monolayers of endothelial cells but have not developed into complex multicellular 
3D systems that recapitulates many important features of healthy blood vessels.  
Multicellularity can be achieved by just mixing different types of cells and culturing them in a 
monolayer as conventional 2D model systems. However, the organization between different 
cell types in vivo are rarely stochastic and have distinct spatial organization in relation to each 
other. The cell-contacts in the human body are cell-cell, cell-air, cell-fluid or cell-scaffolding, 
but in conventional 2D models inevitable have cell-plastic contacts. The latter have been shown 
to negatively impact cell polarity (30), thus hindering the natural spatial organization of cells 
into more organ-like structures. Furthermore, it is becoming increasingly clear that 3D cell 
cultures have more resemblance to their corresponding clinical tissue compared to their 2D 
counterparts in terms of gene expression (31,32). 
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By mixing cells with scaffolding proteins and layer-by-layer add cells, one can artificially 
create spatial differentiation between cells, to then allow for natural formation of more complex 
and detailed tissue structures. Another common method to create 3D structures is to allow for 
cells to form spheroids (33,34), either by gentle vibration to hinder adherence to plastic or using 
the hanging-drop method. Due to their high throughput capacity and relatively complex 
phenotype, and the experience in toxicity screening on monolayer systems, spheroids is 
increasing becoming a popular alternative in drug screening (35,36). 
There is little doubt that complex, multicellular 3D cell culture systems are the next generation 
of cell cultures. However, in the efforts towards developing new, more physiological models 
to study human diseases, it is important to acknowledge the limitations of these models. They 
are far from being 100% representation of their in vivo counterparts, and any interpretations of 
results from these kind of model systems should be made with caution. It may sound impossible 
or sci-fi to imagine that we in the future will be able to grow real tissues that are not only 
suitable for studying diseases but also to transplant and replace permanently damaged tissue. I 
am confident that the technology to execute will be there sooner rather than later, and we would 
do ourselves a favor to be prepared ethically for that time. The continued development and 
validation of methodology is both important for the interpretation of generated data, but more 
importantly to guide the field of organotypic model building to the next phase. 
2.3 TISSUE PERTURBATION 
Tissue perturbation is another way of describing all non-steady state conditions that develop 
over time with or without any external factors involved. The causes of cancer range from highly 
environmental causes in the case of asbestos-related mesothelioma to familial cancer 
syndromes such as Heriditary Breast and Ovarian Cancer (HBOC), but all represent a cell-
perturbation event in the tissue. Infections can be caused by commensal bacteria or pathogenic 
bacteria representing the perturbating event, and autoimmune disorders usually need some 
form of outside trigger to cause disease. Of note, majority of possible tissue perturbing events 
will be influenced by or affect the condition of the immune system.  
Significant progress in medical science, and immunology in particular, have been made by 
studying the behavior of immune cells isolated from blood. However, all diseases occur in, and 
readily involves, a specific tissue that constantly communicates with and adapts to the 
composition of tissue-specific functional cells and extracellular matrix. The inflammatory 
process is a complex phenomenon that rely on the communication and resulting action of all 
cells in the tissue. The host response needs to be able to deal with intracellular and extracellular 
bacteria and viruses, parasites, blunt trauma or sterile tissue damage, defective cells and 
potentially cancerous cells, all whilst still performing important homeostatic functions when 
not currently being threatened. The multifaceted perturbations are all met with variations of 
immune responses that often overlaps with each other. Understanding the phenotype of 
different inflammatory responses will aid us tremendously in the future to develop the next 
generation personalized medicine. 
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2.3.1 Invading microorganisms 
Non-sterile inflammation primarily deals with infections with bacterias, viruses, parasites and 
fungi. These microorganisms all have their unique components that can be recognized by the 
immune system and elicit different types of immune responses. For combating viruses, antigen 
processing, reduced translational activity and cellular immune responses are particularly 
important, whereas most bacteria, parasites and fungi require a more humoral response with 
induction of enhanced phagocytic activity. Fungi and parasite infections in lung are often 
associated with a compromised immune system and/or co-infection with bacteria. In 
developing countries, lower respiratory tract infections cause more death than malaria, HIV 
and tuberculosis combined and are primarily caused by streptococcus pneumoniae, 
haemophilus influenzae type b and RSV. Staphylococcal pneumonias are historically relative 
infrequent, but act as a severe complication of influenza (37), ventilator-induced pneumonia 
(38) and hospital-acquired pneumonia (39). In contrast to streptococcal pneumonias, 
staphylococcal pneumonias often have a more severe clinical presentation and is an important 
cause of death worldwide.  
2.3.2 Tumor growth  
Tumors represent a different type of tissue perturbation. It causes disease by causing a loss of 
function in the primary and secondary tumor-bearing organs and can lead to significant changes 
in blood chemistry. Cell growth and morphogenesis is characterized by a controlled replication 
of cells, that respects the tissue boundaries and organization. Tumor growth do not respect its 
surroundings and causes tissue damage partially by sheer uncontrolled growth.  Furthermore, 
drugs often have a hard time penetrating the tumor mass, as the vascularization is unorganized 
and immature. It is extremely important to find cancer in an early stage, when conservative 
surgary is enough to cure the patient. However, many cancer forms are quiet and do not cause 
any noticeable symptoms, and thus only detected on radiological examination or at a much 
later stage when clinical symtoms become obvious.  
Each time a cell divide, there is a small chance of errors being built into the DNA. Ideally, 
those cells should preferable undergo apoptosis and be replaced by a normal cell. When they 
remain as a dysplastic cell, it is often removed by immune cells that can detect non-self peptides 
or stressed cells by examining the cell surface. In fact, immune cells constantly remove 
defective and potentially cancerous cells, which bears the question: what is the role of the 
immune system when a cancer have managed to escape the safety mechanisms built in? Key 
hallmarks of all cancers are immune evasion and tumorigenic inflammation. The tumorigenic 
inflammation can itself promote immune evasion but certain types of inflammation have tissue-
regenerative potential that promotes cell division, angiogenesis and immune dampening 
properties (28,41). Modulating the immune dampening properties, and/or using checkpoint 
inhibitors to lift the immune evasion have proven to be a successful avenue for a new generation 
of cancer treatments. Especially the use of CTLA-4 inhibitors and PD-1/PD-L1 inhibitors have 
proven promising and useful in a diverse set of cancers, despite immune-related adverse effects 
(42). This suggests that dampening of the immune system to play an important role in cancer 
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progression. The usefulness of these checkpoint inhibitors is far from universal. It is either so 
that the immune evasion strategies are diverse and complex or that some cancer forms depend 
less on its immune dampening properties (43). These are difficult questions to answer but 
identifying which cancer forms are most likely to respond to immune modulating drugs 
remains a priority in cancer research. 
Studying cancer is an extremely difficult task, and the reasons are well summarized in the 
seminal review articles by Hanahan and Weinberg (44,45). A reason that touches upon many 
of the proposed hallmarks is the heterogeneity within the cancer. Cancer is more similar to a 
complex organ, than that of a clonal expansion of a dysplastic cell. Cancer cells themselves are 
heterogeneous, but there are also important co-conspirators within the cancer tissue, such as 
cancer-associated fibroblasts (CAF) (46) and tumor-associated macrophages (TAMs) (47,48). 
The multicellularity and heterogeneity between cancers contribute to the difficulty in creating 
representative model systems to study cancer progression and its interaction with the immune 
system. 
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3 LITTERATURE REVIEW 
3.1 THE RELEVANCE OF ORGANOTYPIC TISSUE MODELS IN STUDYING 
IMMUNE CELL BEHAVIOR IN HEALTH AND DISEASE 
All the studies conducted in this thesis revolves around the utilization of an organotypic tissue 
model presented in Study I, which in turn was a continued development of the work by Choe 
et al (49). The development and utilization of more advanced in vitro models are well in line 
with the concept of the 3 R’s in animal research (Replace, Reduce and Refine) which aims to 
provide a framework for more humane and ethical animal research. In the context of the 
organotypic model system we have developed, one should note that the purpose is not to 
replace animal models but to complement and provide alternative to expensive and not always 
ideal disease models. Importantly, host tropism and species-unique signature of the immune 
system may complicate the interpretation of animal models.  
Organotypic tissue model systems bridge the reductionistic 2D in vitro cultures and animal 
models. What organotypic tissue models lack in complexity compared to animal models, they 
gain in species relevance and experimental setup flexibility. And what they gain in complexity 
compared to 2D in vitro cultures, they lack in scalability. There is no single system that is 
overall superior compared to another.  
As described in Study III, the pathogenesis of staphylococcal pneumonia is highly dependent 
on secreted exotoxins among which, PVL do not cause lysis of neutrophils in murine and 
simian models, but does so in humans and rabbits (50). Thus, studying the totality of S. aureus 
toxicity in mice may result in an overestimation of the contribution of the other toxins released 
by S. aureus, such as alpha-toxin.  
Since the publication of our organotypic lung tissue model, most studies using a similar setup 
primarily focuses on toxicology-related questions in COPD and cigarette smoking. Studies 
using ‘immunocompetent’ models remains few, but attempt have been made to study 
mycobacterial infections (51) and aspergillus fumigatus infections (52).  
The usefulness of immune competent tissue models to study immune cell behavior remains to 
be determined. Promisingly, the model setup has been successfully replicated in different labs 
around the world, and an effort towards validating gene expression profiles of implanted 
immune cells and stromal cells with its corresponding in vivo cells in both steady state and in 
pathological conditions should be prioritized to incentivize more research using these kind of 
model systems. 
3.2 ROLE OF CHEMOKINES IN SHAPING THE INNATE IMMUNE SYSTEM 
Chemokines are chemotactic cytokines that directs and positions immune cells in different 
locales. During acute inflammation in the lung, mast cells are well positioned to quickly 
respond without any transcriptional activity by releasing its pre-formed content. In mouse 
models of airway hyperreactivity or LPS stimulation, CCL1, CXCL1 and CXCL2 have been 
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shown to be released by mast cells to promote early neutrophils recruitment (53,54). For 
sustained influx of innate immune cells, engagement of local immune cells other than mast 
cells via PRRs is crucial. Acute inflammatory cytokines such as IL-1 and TNF are released by 
activated dendritic cells and macrophages which stimulate other resident immune cells and/or 
activates the epithelium and stromal cells. Cytokine-activated epithelium then produces a 
plethora of chemokines, including CXCL8, CXCL1, CXCL2, CXCL3 and CCL5 (55-57). 
Beside neutrophils, monocytes are recruited early to the inflamed tissue but require a different 
set of chemokines. Two important chemokines with known monocyte migration-inducing 
capacity are CCL2 and CX3CL1/fractalkine. When CCL2 is produced, it dimerizes and bind 
to the extracellular matrix and form a chemokine gradient to guide the migration of 
monocytes (58). All monocyte subsets express the fractalkine receptor CX3CR1 which is 
believed to convey survival signals for patrolling monocytes (also known as intermediary 
monocytes) (59) and early migration of classical monocytes (60). Functions of chemokines 
beyond cell migration is a concept we explore further in the context of staphylococcal 
pneumonia in Study IV. For example, monocytes do not migrate towards CXCL8 gradients, 
despite expressing CXCR2. However, CXCL8/CXCR2 interaction have been shown to be an 
important interaction during the adhesion of monocytes to the vascular endothelium (61). 
Fractalkine have similarly been described as an anchoring protein, but its unique regulation as 
a membrane-bound and soluble chemokine suggest multiple mechanisms in which fractalkine 
can shape the monocytic response in inflammatory conditions (62,63).  
In vitro studies of chemokines and immune cell activation is particularly well suited in tissue 
models comprising of scaffolding proteins to support the network of fibroblasts and epithelial 
cells. A common method to study cell migration is boyden chamber (transwell) migration 
assays. The principle is simple; by separating cells to an upper reservoir with a porous 
membrane with a chemokine-rich supernatant in the lower reservoir, migrating cells are 
expected to move from the upper reservoir to the lower reservoir. The chemokine gradient is 
supposedly being formed by diffusion in the supernatant. However, this type of gradient is not 
stable and not comparable to the gradient formed with the help of extracellular matrix proteins. 
It is therefore difficult to assess if cells are plainly activated and start to move in randomly, or 
if they in fact migrate towards the source of stimuli. Furthermore, proteolysis is an important 
aspect of monocytic cell migration, in which podosomes play an important role. Podosomes in 
2D cultures have primarily been defined as adhesion- and mechanosensing molecules and 
traction-generating structures. In 3D matrices, the podosomes are arranged slightly different 
and are larger in size compared to its 2D counterpart. In 3D the podosomes are focused around 
the tip of the cell protrusions that are largely absent from 2D cultured cells (64,65). Studying 
cell migration in physiological relevant context could therefore be especially important in order 
to recapitulate in vivo migration. 
As the concentration of released chemokines are naturally higher around the source, it can be 
misleading to measure chemokine levels in supernatants to determine or create chemotactic 
activity. Allowing for a local source of chemokines, like cytokine or PRR-activated epithelium, 
a more realistic chemotactic scenario can be modelled. With the aim of studying a functional 
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response of implanted dendritic cells, we sought to investigate the possibility to study migratory 
responses following external stimuli of the 3D organotypic tissue model in Study II.  
3.3 PATHOGENESIS OF STAPHYLOCOCCUS AUREUS 
Despite being one of the most common and important human pathogens, it is not entirely clear 
why some are merely carriers are S. aureus and some acquire an invasive, potentially life-
threatening infection. A known complicating factor is co-infection with influenza viruses. 
During the Spanish flue in 1918, an estimated 50 million or 95% of infected people died from 
a pneumonia exacerbated by bacterial co-infection(66). At the time of writing this thesis, we 
are in the middle of a pandemic caused by the 2019 novel coronavirus, SARS-CoV-2. During 
the 2002 outbreak of severe acute respiratory syndrome (SARS) in China, a hospital in Hong 
Kong reported that MRSA was found in 25% of hospitalized ICU-patients during the SARS 
period, and 3,5% and 2,2% pre- and post-SARS period respectively (67). These numbers are 
consistent with the expected magnitude of bacterial superinfection during influenzae infections 
(68), and are to be expected during the current pandemic. As the pneumococcal vaccine is 
gaining increased penetrance in the population, Staphylococcus aureus have risen to 
prominence as a common and deadly cause of secondary bacterial pneumonia. One reason 
for this is likely due to the emergence of USA300 clonotype, causing community-acquired 
methicillin-resistant Staphylococcus aureus (CA-MRSA) infection. It was noted early that 
USA300 express high levels of Panton-Valentine leukotoxin (PVL), a known S. aureus toxin, 
which was and is still believed to be an important cause of necrotic lesions associated with 
the disease (69). However, the precise mechanisms and relative contribution of PVL in 
relation to other S. aureus toxins during necrotizing pneumonia is fiercely debated. Studies 
on PVL are complicated by host specificity, as its receptor C5aR is heterogeneously 
expressed among different species. Studies using humanized mice, i. e mice with a 
reconstituted human immune system, show increased susceptibility to PVL-mediated 
pathology (70). Thus, its precise role in human pathology remains to be fully understood, and 
relevant model systems will significantly aid that endeavour. Bacterial co-infections during 
viral pneumonias may also have deleterious effects as the host immune system is adapting 
towards a viral infection and produces responses that is not well suited to simultaneously 
combat bacterial infections. Influenza virus infection causes damage of the anatomical barrier 
and dead cells mixed into the fibrinous mucus provide a nutrient-rich environment for 
bacteria to thrive (71). It is hard to attribute strain-specific bacterial phenotypes to the 
pathogenesis of bacterial co-infections but is likely to play as important role in determining 
the outcome as virus-specific attributes.  
Another important S. aureus toxin associated with USA300 is alpha-toxin (72,73). Like PVL, 
alpha-toxin is a pore-forming toxin and causes cell lysis. However, unlike PVL, alpha-toxin 
binds to ADAM10 which expressed on most tissues and is a mechanism of action we explore 
further in Study IV. The role of ADAM10-mediated tissue-pathology is especially evident 
when the toxin-concentration is low as ADAM10 functions as a high-affinity receptor. It is 
further complicated by the initiation of intracellular signalling cascades that results in the 
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disruption of focal adhesions (74). Although toxins are only a part of the story in terms of S. 
aureus pathogenesis, it is important to characterize the downstream effects of S. aureus toxins 
in detail in order to find new therapeutic targets. 
3.4 IMMUNE-REGULATING PROPERTIES OF THE TUMOR 
MICROENVIRONMENT. 
The immune system possesses an enormous capacity to recognize and respond to non-self-
antigens. Tumor neoantigens, or tumor-specific antigens, are peptides that are not expressed by 
normal tissue or organs and represent the best avenue for inducing lasting immunity against 
tumors following successful treatments. Early studies showed that mice were protected from 
re-exposure of tumors that have previously been surgically removed or if first exposure of 
tumors were lethally irradiated, suggesting that a memory response could protect the host 
against cancer (75).  These scenarios are of course extremely artificial and not applicable to 
normal disease progression. Additionally, an important tumor-promoting hallmark is immune 
suppression. Even if the nature of tumor neoantigens is still very unclear, the dysplastic nature 
of cancer cells combined with the presence of foreign antigens should have the potential to 
induce strong immune responses, as long as the neoantigens are made available and 
immunogenic and that whatever immunosuppressive mechanisms in play can be thwarted.  
Recent successes in the use of checkpoint inhibitors corroborates this hypothesis as it has been 
shown that tumor mutational burden is correlated to response with anti-CTLA-4 and anti-PD-
1 therapy (76,77). This suggests that the immune system can, but do not, kill cancer cells, and 
that immune suppression play an important role in immune evasion in cancer.  
It is well acknowledged that tumor tissue has organ-like level of organization and complexity. 
Cancer treatment is reaching a paradigm shift, and focus have been on non-cancerous cells, 
such as epithelial cells, immune cells and fibroblasts. By targeting the co-conspirators, a whole 
new treatment arm is slowly being developed for fighting cancer.  
In the tumor microenvironment, lymphocytes express high levels of inhibitory receptors and 
cannot perform their normal function. However, it is not well known what contributes to the 
immune suppressive phenotype of these lymphocytes. Myeloid cells have been implicated as 
a potential suppressive contributor in cancer inflammation. The term “myeloid-derived 
suppressor cells” is as widely used as it is difficult to define accurately. What is clear, is that 
innate immune cells have mechanisms of inhibiting the adaptive arm of the immune system for 
proper resolution of inflammation, as well as protection against overzealous or unregulated 
adaptive responses.  
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4 MATERIAL & METHODS 
4.1 ORGANOTYPIC TISSUE MODEL 
Study I describe the characterization of a “immune competent” organotypic lung tissue model, 
aiming to recapitulate airway wall and mucosa. The foundational structure of the lung tissue 
model was based on the work by Choe et al (49) and includes the addition of monocyte-derived 
dendritic cells. The model setup by Choe et al required the sequential addition of acellular and 
cellular layers of collagen I, 16HBE cells, and air-exposure. Proper maintenance of the lung 
tissue model enables experiments to be carried out well over 4 weeks after maturation. As our 
goal was to incorporate dendritic cells into the model, and there was no continuous supply of 
immune cells to the lung model, we opted to do all analysis within 6-11 days post implantation 
of the dendritic cells.  
The model was developed to provide a tool for studying immune responses in a more 
physiological and relevant context compared to conventional monolayer cell culturing 
methods. Moreover, it adds a new dimension of immune system-pathogen interaction; non-
hematopoietic host cells. Together, it forms the basis of host-pathogen interaction. There are 
three main components of the non-hematopoietic compartment in the lung tissue model used 
in this thesis; lung epithelial cells (16HBE), fibroblasts (MRC-5) and scaffolding (collagen I). 
The model aims to represent the larger bronchial airways or conducting airways where no 
substantial gas-exchange occurs. Lung epithelial cells used in the organotypic tissue model are 
a simian virus 40 (SV40)-immortalized human bronchial epithelial cell. Before the discovery 
of SV40 in 1960, millions of people were administered SV40-contaminated polio vaccines 
which caused a significant public health concern as SV40 was shown to cause cancer in 
laboratory animals. Engels et al have published a series of epidemiological studies indicating 
that SV40 likely does not cause human cancers (78), however contrasted by Meneses et al who 
showed SV40 DNA sequences to be significantly more often detected in lymphomas than in 
control samples (79). In contrast to other cell lines used to represent respiratory epithelium, 
16HBE is derived from a healthy cell, but its histological profile in the organotypic tissue 
model suggest that there are significant differences compared to the bronchial epithelium 
found in vivo. The two most obvious differences are the stratification of 16HBE cells in the 
model, and the lack of ciliation. Respiratory epithelium should be pseudostratified, meaning 
that all cells are resting on the basal membrane. In the organotypic lung tissue model, 16HBE 
cells expand and stratify upon air-exposure, and if left for long enough exposed to air (>7 
days), the epithelium become 5-10 layers thick. An important feature of pseudostratified 
epithelium is the ability to absorb and secrete biological products to maintain tissue 
homeostasis. Another aspect of respiratory epithelium is that it is not homogenous but contain 
different cell types with various functions. For example, goblet cells are specialized in 
producing mucus and basal cells are precursor cells embedded in the pseudostratified 
epithelium. Acknowledging these differences significantly impacts which type of questions 
that can be asked using the organotypic tissue model, and how the experimental outcomes 
are limited when testing other hypotheses.  
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Studies on microbial colonization is challenging, as the environment is still very beneficial 
for most microbes and requires extensive optimization and limitation on type of assays for 
the model to not be overgrown with bacteria. To study how stromal cells and immune cells 
interact, we have used two principally different strategies in the included studies. One way 
was to allow for implantation of monocytes or dendritic cells into the organotypic lung tissue 
model and measure the effects following isolation of the cells or compared to a control tissue. 
This approach was particularly important in Study II and V, as we expect cell migration to 
be one of the cell functions that will differ significantly when comparing conventional in 
vitro experiments and the in vivo setting. The second approach was to take supernatant from 
the organotypic tissue model exposed to a perturbance and “expose” freshly isolated 
monocytes to the tissue-derived soluble factors. Although the lack of cell-contact dependent 
mechanisms that may influence the response, we have thought of it as a model where blood 
monocytes arrive to a specific tissue and are exposed to all the factors induced by for example 
a staphylococcal toxin. The second approach was significantly easier to scale up, and where 
cell number never is an issue. The first approach is potentially the most desirable option, but 
depending a labs technical limitation, it is not always the best option.  
Respiratory epithelium also has a temperature slightly below core temperature, as cold or 
room-temperature air is constantly flowing across the epithelium. Although the temperature 
difference is not as big as compared to skin, a couple of degrees may still influence immune 
cell function (80,81). The lack of blood flow is addressed by regularly changing the media 
that is in contact with the basolateral side of the model, but compared to normal blood vessels, 
it does not provide an avenue for replenishment of immune cells that would normally 
contribute to the removal of dead cells. Thus, cell debris will accumulate in the model and 
likely contribute to the steady state profile that we observed.  
4.2 MONONUCLEAR PHAGOCYTIC CELLS 
Magnetic cell separation, also called immunomagnetic cell separation, provide one of the most 
common and reliable methods for isolating specific cell population with high purity. As we 
sought to recapitulate a steady state tissue that could respond to exogenous substances and 
pathogens, we tried to populate the tissue with dendritic cells by differentiation monocytes 
isolated from blood.  
A reason for not choosing to model tissue-resident adaptive immune cells is the mis-match 
compatibility issue with tissue cells from another host. Granulocytes proved to be short lived 
and easily activated. Other immune cell candidates included monocytes and macrophages. 
Monocytes were and is still considered to not have a lung-resident specific phenotype, and 
more prevalent during inflammation rather than steady state. The use of macrophages was 
complicated by the differentiation protocols that forced the cells into extremely polarized 
phenotypes which would be difficult to assess after exposure to exogenous stimuli. 
Furthermore, at the time of developing the lung tissue model, little was known about interstitial 
macrophages, their ontogeny, localization and phenotype. Most macrophage-related work in 
lung have been directed towards alveolar macrophages (AMs), in part due to the high numbers 
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of AMs attained during a BAL wash. Only recently have interstitial macrophages been more 
thoroughly characterized (82). In the end, our longstanding interest in cell chemotaxis and the 
immune surveillance capabilities made us consider DCs as our initial point of focus.  
Dendritic cells as a whole are extremely rare, and the amount of lung tissue needed in order to 
isolate enough primary tissue-resident dendritic cells would be impractical. Even the frequency 
of blood DCs are too low for reliably producing any larger numbers of tissue models. 
Monocyte-derived dendritic cells have long been used as a substitute for de novo DCs and there 
are well established protocols to reliably attain high numbers of moDCs. As these cells were 
differentiated with IL-4 and GM-CSF, at best they represent a DC-like cell under inflammatory 
conditions. For the purpose of characterizing immune implantation in the model, and studies 
of DC migration, the limited relevancy of moDCs was acceptable to us. For studies where our 
main interest lies in finding an altered phenotype as a consequence of a tissue response, we 
opted to use freshly isolated monocytes that where stimulated with supernatants from the 
organotypic tissue models. Instead of creating a model to study resident immune cells, this 
approach would represent infiltrating monocytes to the lung tissue that are exposed to the 
soluble factors produced by epithelial cells and fibroblasts. Experimentally, it proved to be a 
highly reproducible system that allowed for multiparametric flow cytometry analysis and 
functional assays of the monocytes after exposure to the tissue microenvironment. 
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5 RESULTS & DISCUSSION 
5.1 STUDY I 
This study describes a diverse array of methods to study functional properties of dendritic cells 
in a physiological relevant milieu. By histologically characterizing the organotypic lung tissue 
model, we conclude that it shares many features with real lung tissue and that its three-
dimensional organization is self-sustainable and show characteristics not present in 
reductionistic monolayer systems. For example, the formation of a basal membrane on the 
basolateral side of the 16HBE epithelial layer and a mucous layer on the apical side are not 
observed in conventional cell culture settings. The main structural component of the tissue 
model when forming it is collagen I, but over time as the tissue model matures – extracellular 
matrix proteins such as collagen IV, vimentin and tropoelastin is deposited and provide a much 
more complex and physiological environment than conventional cell culture methods can do. 
Immune cells invariably interact with ECM proteins, and it provide a particularly important 
function in the context of chemokine regulation.  
The organotypic lung model consist of three different cell types; epithelial cells, fibroblasts and 
monocyte-derived dendritic cells (moDCs). Importantly, the moDCs survive without the 
addition of exogenous growth factors (Figure 4D). Cryosectioning and whole-mount live 
imaging show that dendritic cells are closely associated to the epithelium throughout the 
maturation of the model. If the maintenance of dendritic cells in the lung model is mediated via 
cell-cell contacts or soluble factors was not tested, but the high expression of GM-CSF mRNA 
in the organotypic lung model suggest that survival-promoting signals are present in the lung 
model.  
Although occasional biopsies from the bronchial tree can have a stratified epithelial 
appearance, bronchial epithelium is a pseudostratified epithelium. Prolonged air-exposure of 
the organotypic lung model tend to induce a stratified squamous epithelium-looking 
appearance and reaches a maximum of 10 layers. The 16HBE cells used to form the epithelial 
layer does not ciliate in our model, which is also a sign of an undifferentiated bronchial 
epithelial cells. Thus, the epithelial layer in the model effectively function as a physical barrier, 
but its representation of the in vivo bronchial epithelium and its barrier function can be 
questioned, even if the organotypic model as a whole supports the survival of dendritic cells. 
The pathological interplay between dendritic cells and epithelial cells is a well-known 
phenomena in asthmatic inflammatory reactions (83-87). Although much focuses on the 
secreted factors by epithelial cells that induces dendritic cell activation, the communication 
goes both ways. Less is known about the interaction between dendritic cells and epithelial 
cells in steady state. In Figure 7, we demonstrate how the chemokines secreted from the 
organotypic model is affected by the presence of dendritic cells. The number of dendritic 
cells decrease over time (Figure 5) which would suggest that any increases in the chemokine 
secretion is more likely to be secreted by epithelial cells. However, CCL18 is a chemokine 
predominantly secreted by monocytes/macrophages and DCs. The organotypic model alone 
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expectedly did not produce any CCL18, and moDCs alone showed low but detectable levels. 
But when the dendritic cells were implanted to the organotypic model, the expression increased 
drastically. It is unlikely that detected CCL18 come from the dendritic cells before they were 
implanted, as the number of dendritic cells decreases over time and media is changed every 48 
hours post implantation. Thus, the remaining dendritic cells are likely modulated by the tissue 
model to secrete more CCL18. In addition, supernatants from separately cultured cells (16HBE 
and MRC-5) were not able to induce CCL18 expression in DCs, whereas supernatant from 
organotypic model with 16HBE + MRC-5 cells could, another example of the phenotypic 
difference cells have in 3D matrices compared to conventional 2D in vitro cultures.  
In contrast to CCL18, which is found at high levels in plasma during steady state, CCL17 and 
CCL22 are induced upon inflammation, mainly in relation to Th2-activation. These 
chemokines were not further induced by the organotypic tissue model as CCL18 was. It is 
tempting to suggest that the organotypic model induces a steady-state phenotype in the 
dendritic cells. In some aspects, and in relation to the high inflammatory phenotype of moDCs, 
that could be the case, but the high expression of IL-1ß, TNF and CXCL8 mRNA in the model 
contradicts that notion. A constant low-grade inflammatory environment is possible, although 
the immunological and tissue-response needs to be tightly regulated in the lung and 
consequently balanced with other immunosuppressive actions (88,89). 
The relevancy of GM-CSF and IL-4 differentiated dendritic cells can also be questioned. These 
cells most likely have an inflammatory phenotype compared to de novo dendritic cells and 
have previously been expected to only appear during infection or sterile inflammation (66-68). 
However, monocytes have been shown to differentiate to dendritic cells under steady state 
conditions in lung (25). Whether this represent the “non-sterile” environment of lung, or if 
there are specific properties in the steady-state lung microenvironment, remains to be 
investigated. Tissue-resident immune cells in the lung microenvironment are of particular 
interest in autoimmune reactions, such as asthma, and their phenotype is becoming increasingly 
well understood (90,91), but the inaccessibility of human tissue-resident cells make them 
difficult to study mechanistically. Although the resemblance of the organotypic lung model 
and real lung tissue have clear limits, the findings in Study I warrants further exploration of the 
phenotypic changes induced in the dendritic cells following implantation to a 3D multicellular 
and physiologically relevant milieu. 
5.2 STUDY II 
Study II show that dendritic cells implanted in the organotypic lung model are functional, and 
that its migratory properties can be visualized and quantified whilst still in the organotypic 
model.  
In study I, we could measure the impact of the 3D organotypic model on dendritic cells in terms 
of survival and chemokine expression. Study I suggest that DCs in the organotypic model are 
functional, although the decline of DCs over time could potentially indicate that the cells are 
dying and/or non-functional. An archetype function of DCs is migration and considering the 
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expression of chemokines in the organotypic lung model, we sought to find direct evidence of 
functional DCs in the model by quantifying DC migration using live confocal microscopy. By 
utilizing genetically modifying 16HBE and MRC-5 cells to express GFP and orange 
fluorescent proteins, respectively, we could observe two distinctly separated cell layers – a 
fibroblast-layer and an epithelial layer. The confocal microscope was able to penetrate 
approximately 150µl beneath the top part of the epithelial layer. As dendritic cells were 
constantly closely associated to the epithelial layer (≈20-40 µm thick), all dendritic cells could 
easily be visualized.  
Tissue-sectioning using cryopreserved or paraffin-embedded tissues have severe limitations 
when examining rare cell subsets. The way the model is built makes it particularly difficult to 
study the cells via immunohistochemistry, as each section consist only of a minimal area where 
DCs could possibly be detected. For quantification purposes, immunohistochemistry of fixed, 
sectioned tissue is not suitable. Relative numbers of DCs could be quantified using 
multiparametric flow cytometry, but the loss of cells during tissue processing makes flow 
cytometry less than ideal for absolute counts of rare cell subsets. Therefore, in Study I, we 
developed a method to visualize all implanted dendritic cells using cell tracker dyes and GFP-
expressing 16HBE cells. By transferring the model and some media onto a microscope-friendly 
6-well plates, multiple models can be imaged simultaneously and the DCs relative position to 
Even in the absence of any stimulating agents, we could see that DCs were spontaneously 
moving around in the model over time. When stimulating with TLR2 and TLR4 ligands, to 
provoke an epithelial response and DC activation, we observed that DCs were closer, and more 
often inside, the epithelium compared to the unstimulated models. 16HBE cells express both 
TLR2 and TLR4, and are able to respond to for example LPS. However, they also express 
lower levels of MD-2, an adaptor molecule for TLR4. It has been suggested that the general 
hypo-responsiveness in lung is an important homeostatic mechanism and partly mediated by 
the differential TLR-activation in lung epithelial cells compared to other organs (15,16,92,93). 
The association of DCs to the epithelial could be either an indirect effect of epithelial-induced 
chemokine secretion, or a general increase in motility of DCs through direct TLR-activation 
and that the presence of the anchoring chemokine fractalkine (CX3CL1) (Study I: Figure 4D, 
Study IV: Figure 2A) leads to a higher ratio of DCs associated with the epithelium. It should 
also be noted that the relative position of every single DC varies widely within each model, 
irrespective of stimuli. This could represent potential DC heterogeneity, cell viability or 
stiffness of the model. In contrast to 2D migration, DCs in the organotypic model are forced to 
interact with extracellular matrix in all directions and may even require some degree of 
proteolysis for any significant cell displacement. Although meaningful directionality can only 
be quantified in the Z-axis (apical-basolateral), the addition of XY-plane displacement enables 
the quantification of the total distance travelled and speed of each individual DC. DCs from 
TLR-stimulated models exhibited both faster and longer distances travelled per time unit. 
Additionally, migrating cells constantly reorganizes the cytoskeleton and larger protrusions can 
be observed in migrating cells compared to stationary cells. The cell-tracker dyes enabled us 
to create 3D surfaces of the individual cells, representing the outline of each cell. Activated 
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cells, and motile cells, were less spherical which correlated with the mean speed of the 
individual DC in all stimulated models (Fig 4).  
Using the 3D organotypic model setup combined with confocal microscopy, spatial and 
temporal quantification of DC migration under tissue perturbation is possible. The main 
drawback with cell-tracker dye systems is that is indiscriminately stain all living cells. Even if 
cell purity is high, it cannot account for phenotypic changes and cell viability. For example, 
activation of DCs with TLR-ligands induces upregulation of co-stimulatory molecules CD80, 
CD86 as well as upregulation of HLA-DR and CCR7. The activated phenotype should 
theoretically be linked to the increased migratory capacity. Although we could detect an 
activated phenotype of DCs after isolation from the model and staining for flow cytometry 
(Figure 5), it is no longer possible to dissect the migratory properties in relation to their 
phenotype on a single-cell basis.  
5.3 STUDY III 
Our increasing experience with the organotypic tissue model led us to test the usefulness of the 
model in a pathogenic setting. One of the most serious respiratory infections are staphylococcal 
pneumonias, but the pathogenesis behind severe necrotizing pneumonia remains controversial. 
This is partly due to lack of relevant model systems, but also due to the abundance of toxins 
expressed by S. aureus. Differences in clinical presentation, severity and relative expression of 
virulence factors further complicates the dissection of staphylococcal pneumonia pathogenesis.  
As addition of live, whole bacteria to the model would quickly render the model system 
overpopulated with bacteria and unusable for further analysis, we used a bacterial supernatant 
to stimulate the organotypic lung model. By culturing 31 different S. aureus isolates with 
different clinical presentations and toxin-properties, we found that supernatants with high 
levels of bacterial toxins correlated with tissue disintegration. The damage seen in the 
organotypic tissue model could be correlated with the clinical presentation of the patients from 
which the S. aureus strains were isolated from. A frequent debate in S. aureus pneumonia 
pathology is the relative contribution of alpha-toxin vs PVL as a cause for the severe clinical 
outcome. Our data suggest that alpha-toxin causes tissue damage through its direct interaction 
with epithelial cells, whereas PVL causes indirect epithelial injury as supernatant from PVL-
treated neutrophils, but not PVL alone or control-treated neutrophils, were as effective as alpha-
toxin in inducing epithelial injury. Thus, suggesting that two toxins independently of each other 
contributes to tissue pathology and exacerbates one another. Using the same experimental setup 
as in Study II, but without the addition of dendritic cells, we could quantify the tissue damage 
over time as a function of loss of GFP in the epithelial cells. Live imaging and 
immunohistochemistry showed reduced signs of tissue disruption and loss of E-cadherin in S. 
aureus strains expressing high levels of alpha toxins and stimulation with pure alpha-toxin, but 
not with recombinant PVL or supernatants from S. aureus strains expressing high levels of 
PVL, and low levels of alpha-toxin.  Notably, the effect on cell-cell interacting molecules were 
not global as evident by the relatively unchanged claudin 1 staining-pattern after stimulation 
with bacterial supernatant. Pre-treatment of the bacterial supernatant with IVIG blunts alpha-
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toxin mediated cytotoxicity in epithelial cells and PVL-mediated cytotoxicity in neutrophils. 
Neutrophil recruitment is essential in all types of bacterial infections, but their sensitivity 
towards PVL may cause more collateral damage than intended. The solution is not to hinder 
the recruitment of neutrophils, but to find ways of protect neutrophils whilst they are combating 
the bacteria. Since this published work, IVIG have been shown to confer protection against 
necrotizing phenotype of MRSA pneumonia in a rabbit model (94). Nosocomial S. aureus 
infection in neonates have also been shown to benefit from IVIG (95). Although any findings 
made in the organotypic tissue model pertaining to mechanisms of pathogenesis needs to be 
tested and validated in other model systems and in vivo, the organotypic model can cleary be 
used as a hypothesis-generating platform for deciphering complex pathogenic mechanisms 
of S. aureus. One example of such hypothesis-generating experiments could be to identify 
which molecules present in the PVL-stimulated PMN supernatant are most important for 
exacerbating toxin-mediated tissue injury.  
5.4 STUDY IV 
The stimulation of the lung tissue model with bacterial toxins caused severe tissue damage by 
evidence of histological examination. The loss of E-cadherin and relatively unaffected levels 
of claudin 1 suggest that there are enzyme-specific or cell-modulatory events in play. ADAM10 
have previously been identified as a receptor for alpha-toxin, and it coincidentally also targets 
E-cadherin when activated. To test the hypothesis if ADAM10 confers the alpha-toxin 
mediated tissue injury, we set up a series of experiments aimed at blocking the down-stream 
pathway of ADAM10. Indeed, inhibition of ADAM10 protected the tissue model from injury. 
As ADAM10 have multiple substrates, and alpha-toxin specifically binds to ADAM10, we 
speculated that downstream of ADAM10 activation may have implications related to the 
immunity of S. aureus infection. In Study I, we had already confirmed the expression of 
fractalkine on mRNA level. Fractalkine is a known target of ADAM10, which naturally made 
us ask the question what potential role of ADAM10-mediated fractalkine cleavage had in S. 
aureus infection. Notably, plasma levels of fractalkine is elevated in patients with S. aureus 
infection compared to healthy controls. Pachot et al have seen a similar pattern in a sepsis 
cohort, and speculate that the loss of membrane-bound fractalkine from the endothelium may 
contribute to the inability to kill invading microorganisms as fractalkine have been suggested 
to induce arrest and transmigration of patrolling monocytes. However, fractalkine is unique in 
that it is both functional in its membrane-bound form and soluble form. We show that 
monocytes can migrate towards a CX3CL1 gradient, and that blockade of ADAM10 activity or 
alpha-toxin activity shunts CX3CL1-mediated migration. Fractalkine have also been shown to 
have non-chemotactic functions in NK cells, as it induces IFNg production in its 
membrane/immobilized form compared to the soluble variant. As fractalkine is released in 
systemic S. aureus infections and S. aureus pneumonias, we stimulated monocytes with 
fractalkine and observed phenotypic and functional changes that could be relevant for their 
anti-bacterial function. Of particular note, we found that monocytes that were pre-treated with 
fractalkine and then infected with S. aureus had lower production of NO and ROS. Taken 
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together, the findings in Study IV proposes fractalkine cleavage to contribute to S. aureus 
pathogenesis by modulating monocyte function.  
This study is very much focused on the single downstream events of alpha-toxin and ADAM10 
leading to fractalkine cleavage. As bacterial toxins in S. aureus are numerous and the substrate 
specificity of ADAM10 is broad, we do not exclude that the fractalkine effect in vivo is 
negligible or redundant. However, the notion that chemokines have functions beyond cell 
migration is worth exploring and could drastically improve our understanding of complex 
networks of chemokine profiles in health and disease.  
5.5 STUDY V 
Here we describe a model system for studying tumor growth and interaction with immune cells. 
By using a similar setup as in Study II, we implanted different tumor spheroids formed using 
the hanging drop-technique.  This enabled us to visualize defined foci of tumor-rich areas using 
confocal microscopy and quantify how the dendritic cells spatially organized themselves in 
relation to the tumor spheroid.  Dendritic cells in models that were implanted with A549 tumor 
spheroids, were found at a higher frequency in the tumor area compared to H1299 tumor 
spheroids and 16HBE control spheroids. We could also observe changes in soluble factors 
secreted by the model depending on the implanted tumor spheroids in terms of chemokines and 
ability to alter monocyte phenotype. The H1299 tumor model supernatant showed higher levels 
of secreted chemokines and had higher impact on expression of co-stimulatory molecules on 
monocytes following an 18-hour co-culture. The altered expression of co-stimulatory 
molecules was mainly seen as an upregulation of CD83 and PD-L1, and a down-regulation of 
CD86 which could be indicative of a less activated phenotype. Interestingly, the same pattern 
could be replicated with the control 16HBE spheroid supernatants if the models were pre-
incubated with IL-1b. Blockade of IL-1b have been shown to confer a degree of protection 
against developing lung cancer {R(96)and is therefore believed to have tumor promoting 
actions in the tumor microenvironment. A possible mechanism could be modulation of innate 
immune cells as a consequence of chronic inflammation, in part mediated by IL-1b. 
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6 CONCLUDING REMARKS 
A central and recurring question following the discussion and presentation of results from the 
studies included in this thesis is:  
What is the (potential) role of organotypic tissue models in medical research? 
In my early exploration of organotypic tissue model, I was of the belief that diseases needed to 
be modelled in order to be studied comprehensively. Interrogating experimental setups by 
changing one parameter at the time in a disease setting seemed like the most natural and 
reasonable way to understand dynamic processes. I also felt that work related to human 
material/biopsies only described snapshots of a disease, and that heterogeneity within diseases 
would make it nearly impossible to understand the pathogenesis of a disease, and only provide 
descriptions on a limited number of situations.  
The unprecedented evolution of big data research in all fields is slowly changing my mind. 
Although the research community is currently generating much more data than we could 
possibly handle, let alone make sense of, we are building a gold mine for future scientists to 
explore. The more data we can collect, the better – and it is only a matter of time before we 
have the tools to be able to properly organize and understand the collected data. Combining big 
data from biological material and behavioral patterns on an individual and societal level will 
enable creative comparisons and opportunities to ask specific questions that previously only 
was possible by reducing complexity and limiting variables to its extreme in 
biological/experimental models. The key difference between data generated from in vitro 
models and in vivo samples is that, except for the methodological limitations, the data 
generated from material collected from an individual are always true. It can be an outlier or not 
a representative description of that particular disease, but the set of data is always true for that 
individual with the specific disease. In vitro data is only true for that specific experimental 
setup, which in best case scenario share features with its in vivo correlate.  
If I were to guess on how organotypic tissue models would be used in the future, I would say 
it is in the pharmaceutical industry where screening for drugs requires more valuable output 
data than is currently the case. The field of toxicity screening have already implemented large-
scale usage of models more complex than 2D cell cultures. 3D organotypic models could also 
be used as a screening tool that include not only the drug as variable parameter but incorporate 
the patient’s own cells as part of the model and function as a variable in an effort to create 
personalized medicine. For organotypic tissue models to be useful in this context, validation of 
its tissue-resemblance is key. Organotypic tissue models could also potentially be used in 
transplantation settings, where it could provide a tissue-framework for proper 
regeneration/healing of damaged tissue, i.e. skin transplants. Organs that have the simplest, and 
most homogeneous histological organization are probably the best candidates for this type of 
use. Cornea, liver and pancreas could be some of the candidate organs, beside skin, that are 
worth trying to develop in vitro for transplantation purposes. The usefulness of organotypic 
tissue models as hypothesis-generating platforms remains to be proven. Today, it is likely too 
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laborious and inefficient for wide implementation in immunological research as the 
organotypic tissue models are far from not near perfect representation of real tissues. As I 
mentioned earlier, organotypic tissue models are not better or worse than any other model – 
but it is different compared to 2D culture systems. In some respect, the differences may be in 
favor of organotypic tissue models. In other instances, it complicates the interpretation and I 
believe it is fair to say that organotypic tissue models to date cannot be regarded as a “golden 
standard”-method to test any hypotheses specifically addressing disease pathogenesis, 
especially as it is unlikely to find comparable datasets to relate data generated using 
organotypic tissue models. Although, as a hypothesis-generating platform, I am more 
optimistic seeing a place for the use of organotypic tissue models. 
Finally, I am hopeful that organotypic tissue models will play an increasingly larger role in 
medical research in the future and that the work in this thesis represents methodological proof-
of-concepts which can be further explored with confidence once comprehensive validation and 
continued development of the model systems are further along.  
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